Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02753686
Title Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy (Treat ER+ight)
Acronym Treat ER+ight
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Burnaby British Columbia V5G 2X6 Canada Details
Novartis Investigative Site North Vancouver British Columbia V7L 2L7 Canada Details
Novartis Investigative Site Richmond British Columbia V7C 5L9 Canada Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Moncton New Brunswick E1C 6Z8 Canada Details
Novartis Investigative Site Moncton New Brunswick E1C 8X3 Canada Details
Novartis Investigative Site Cambridge Ontario N1R 3G2 Canada Details
Novartis Investigative Site Kingston Ontario K7L 5P9 Canada Details
Novartis Investigative Site Kitchener Ontario N2G 1G3 Canada Details
Novartis Investigative Site London Ontario N6A 5W9 Canada Details
Novartis Investigative Site Newmarket Ontario L3Y 2P9 Canada Details
Novartis Investigative Site Ottawa Ontario K1H 8L6 Canada Details
Novartis Investigative Site Sault Ste Marie Ontario P6A 2C4 Canada Details
Novartis Investigative Site Toronto Ontario M2K 1E1 Canada Details
Novartis Investigative Site Toronto Ontario M4C 3E7 Canada Details
Novartis Investigative Site Toronto Ontario M5B 1W8 Canada Details
Novartis Investigative Site Windsor Ontario N8W 2X3 Canada Details
Novartis Investigative Site Greenfield Park Quebec J4V 2H1 Canada Details
Novartis Investigative Site Montreal Quebec H3A 1A1 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Montreal Quebec H4J 1C5 Canada Details
Novartis Investigative Site Regina Saskatchewan S4T 7T1 Canada Details
Novartis Investigative Site Saskatoon Saskatchewan S7N 4H4 Canada Details
Novartis Investigative Site Quebec G1S 4L8 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field